BR9106772A - Processo para tratar e evitar a infeccao por virus da imunodeficiencia humana em individuos mamiferos,incluindo o homem,dispositivo atomizador,composicoes para aplicacoes topica,administracao gastrointestinal,parenteral,transdermica,para revestir equipamento medico,revestimento polimerico e peptideos - Google Patents

Processo para tratar e evitar a infeccao por virus da imunodeficiencia humana em individuos mamiferos,incluindo o homem,dispositivo atomizador,composicoes para aplicacoes topica,administracao gastrointestinal,parenteral,transdermica,para revestir equipamento medico,revestimento polimerico e peptideos

Info

Publication number
BR9106772A
BR9106772A BR919106772A BR9106772A BR9106772A BR 9106772 A BR9106772 A BR 9106772A BR 919106772 A BR919106772 A BR 919106772A BR 9106772 A BR9106772 A BR 9106772A BR 9106772 A BR9106772 A BR 9106772A
Authority
BR
Brazil
Prior art keywords
equipment
composities
treat
human immunodeficiency
atomizing device
Prior art date
Application number
BR919106772A
Other languages
English (en)
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Syntello Vaccin Dev Kb Companh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Vaccin Dev Kb Companh filed Critical Syntello Vaccin Dev Kb Companh
Publication of BR9106772A publication Critical patent/BR9106772A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR919106772A 1990-08-22 1991-08-20 Processo para tratar e evitar a infeccao por virus da imunodeficiencia humana em individuos mamiferos,incluindo o homem,dispositivo atomizador,composicoes para aplicacoes topica,administracao gastrointestinal,parenteral,transdermica,para revestir equipamento medico,revestimento polimerico e peptideos BR9106772A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57108090A 1990-08-22 1990-08-22
PCT/SE1991/000544 WO1992003147A1 (en) 1990-08-22 1991-08-20 Peptides that block human immunodeficiency virus infections and methods of use thereof

Publications (1)

Publication Number Publication Date
BR9106772A true BR9106772A (pt) 1993-07-20

Family

ID=24282265

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106772A BR9106772A (pt) 1990-08-22 1991-08-20 Processo para tratar e evitar a infeccao por virus da imunodeficiencia humana em individuos mamiferos,incluindo o homem,dispositivo atomizador,composicoes para aplicacoes topica,administracao gastrointestinal,parenteral,transdermica,para revestir equipamento medico,revestimento polimerico e peptideos

Country Status (17)

Country Link
EP (1) EP0545991B1 (pt)
JP (1) JP3115596B2 (pt)
KR (1) KR100220531B1 (pt)
AT (1) ATE173934T1 (pt)
AU (1) AU667290B2 (pt)
BR (1) BR9106772A (pt)
CA (1) CA2088788C (pt)
DE (1) DE69130571T2 (pt)
DK (1) DK0545991T3 (pt)
ES (1) ES2128322T3 (pt)
FI (1) FI930519A (pt)
GR (1) GR3029523T3 (pt)
HU (1) HUT63177A (pt)
MC (1) MC2306A1 (pt)
NO (1) NO930401L (pt)
OA (1) OA10051A (pt)
WO (1) WO1992003147A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009523157A (ja) * 2006-01-13 2009-06-18 オンコレー アーベー 虚血および神経変性の処置のための化合物
FR2925500B1 (fr) * 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925501B1 (fr) 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108022T1 (de) * 1985-10-24 1994-07-15 Southwest Found Biomed Res Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
NO930401L (no) 1993-02-17
AU667290B2 (en) 1996-03-21
AU8433291A (en) 1992-03-17
FI930519A (fi) 1993-04-21
JPH06504035A (ja) 1994-05-12
ATE173934T1 (de) 1998-12-15
FI930519A0 (fi) 1993-02-05
GR3029523T3 (en) 1999-06-30
EP0545991B1 (en) 1998-12-02
JP3115596B2 (ja) 2000-12-11
CA2088788A1 (en) 1992-02-23
WO1992003147A1 (en) 1992-03-05
NO930401D0 (no) 1993-02-05
HU9300456D0 (en) 1993-05-28
EP0545991A1 (en) 1993-06-16
DE69130571D1 (de) 1999-01-14
HUT63177A (en) 1993-07-28
MC2306A1 (fr) 1993-09-27
DK0545991T3 (da) 1999-08-16
CA2088788C (en) 2003-12-16
KR100220531B1 (ko) 1999-10-01
DE69130571T2 (de) 1999-06-17
OA10051A (en) 1996-10-14
ES2128322T3 (es) 1999-05-16

Similar Documents

Publication Publication Date Title
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
TR199903053T2 (xx) Benzimidazol t�revleri.
ES541103A0 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
HUT55050A (en) Process for producing albumin derivatives and pharmaceutical compositions comprising same
CY1106615T1 (el) Μεθοδος επιταχυνσης αναρρωσης ενος τραυματος χρησιμοποιωντας συνθετικες ή φυσικες οντοτητες που προσομοιωνουν την αποπτωση
ATE123950T1 (de) Prophylaktische und therapeutische anwendungen von peroxidasen.
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
BR9808100A (pt) Utilização de amandantina para tratamento de hepatite c.
BR9106772A (pt) Processo para tratar e evitar a infeccao por virus da imunodeficiencia humana em individuos mamiferos,incluindo o homem,dispositivo atomizador,composicoes para aplicacoes topica,administracao gastrointestinal,parenteral,transdermica,para revestir equipamento medico,revestimento polimerico e peptideos
WO2003061602A3 (en) Combination therapy for treatment of hiv infection
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
NO970847D0 (no) 2-£amino-6-(cyklopropylamino)-9H-purin-9-yl|-2-cyklopenten-1-metanol-succinat som anti-virusmiddel
CA2007499A1 (en) Treatment methods and vaccines for stimulating an immune response
DE60143668D1 (de) Peptidinhibitoren gegen den eintritt von hiv in zellen
DK0687181T3 (da) Metode til behandling af hepatitis C hos individer, som ikke responderer på interferon-behandling
HUP0100937A2 (hu) Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen
RU93005034A (ru) Пептиды, блокирующие инфекцию вируса иммунодефицита человека, способы их применения
AU2396900A (en) Treatment and prevention of hiv and other viral infections
BR0008269A (pt) Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
BR9708720A (pt) Composição farmacêutica e processo para o tratamento de demência por hiv.
James Remune trial will stop; new trials planned
TH13481A (th) วัคซีนและวิธีการใช้สำหรับไวรัสภูมิคุ้มกันโรคบกพร่องในมนุษย์
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: C07K 7/06 (2006.01), A61L 27/34 (2006.0